Kay Makishi

Single Family Office | Secondaries | LP Investor into Funds, Companies | US-Japan Cross Border Business

📍 United States🔄 Updated September 2026💼 5 investments📅 6 years investing🗓 Last invested Oct 2024
VC🌍 United States
5
Total investments
0
Early stage
1
Mid stage
1
Late stage
6y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Early Stage VC - Investor
Oct 2024
Oxonian Ventures is the leading early-stage venture fund investing in Oxford alumni founded companies, using investment capital from Oxford alumni and affiliated institutions. With a portfolio of over 30+ companies Oxonian Ventures brings together Oxonian founders and investors to move ventures forward and elevate the visibility and reputation of Oxonian founded companies.
Early Stage VC - LP Investor via LSFO
2024
Critical Venture Partners is an inception stage venture capital firm that partners with exceptional students tackling major crises.
Early Stage VC - LP Investor via LSFO
2024
Rethink Food is a venture strategy out of the Rethink Capital Partners platform investing in early-stage companies that leverage technology to provide sustainable and accessible food solutions.
Early Stage - Investor via LSFO
2024
We innovate to address the crises of food waste and hunger by producing tasty, inexpensive food products from surplus and fresh-cut remnants. We bridge gaps in local food systems by using misshapen, yet still-nutritious, rejected, landfill-bound vegetables. We transform systems by reimagining logistics, changing consumer demand, and encouraging enthusiasm for variety.
Board Member
Sep 2020
The Oxford Alumni Association of New York (OAANY) brings together alumnus of the University of Oxford who are based in the New York area. For further information, follow us on LinkedIn and Instagram, and subscribe to our newsletter.
Experience · 13 entries
All (13)
Investments (5)
Founder (1)
Board (1)
2025
Early Stage VC - Mentor
Jan 2025
Techstars helps founders scale their startups into world-changing businesses. Founded in 2006, Techstars is on a mission to invest in startups to enable more capital to flow to more entrepreneurs around the world in order to deliver exceptional returns to our investors. We do this by operating accelerator programs and venture capital funds, as well as by connecting startups, investors, corporations, and cities to help build thriving startup communities. Our results show why Techstars is Better for Founders than any other global accelerator: On average, 74.5% of Techstars companies will raise money within 3 years of their program; 18.5% of Techstars portfolio companies have exited 5 years after their program and 31.1% after eight years. (PitchBook June 2023)
2024
Vice President
Oct 2024
Lupoff/Stevens Family Office, manifests the various activities of family members, including investments, social and environmental programmatic activations, academic work, advisory and projects of the Family. The Lupoff/Stevens Family Office is committed to fomenting a just and sustainable planet, seeking acceptable financial returns along side demonstrable social/environmental impact benefiting people and planet from our 100% Impact/Responsible Investment Portfolio. Our investment mandate and policy objectives support social and climate equity and justice.
Early Stage VC - Investor
Oct 2024
Oxonian Ventures is the leading early-stage venture fund investing in Oxford alumni founded companies, using investment capital from Oxford alumni and affiliated institutions. With a portfolio of over 30+ companies Oxonian Ventures brings together Oxonian founders and investors to move ventures forward and elevate the visibility and reputation of Oxonian founded companies.
Advisor
Jan 2024
Mount Sinai Innovation Partners (MSIP), the technology commercialization arm of the Mount Sinai Health System, facilitates the transfer of discovery from the laboratory to the marketplace, acting as the interface with commercial entities. MSIP is responsible for the full spectrum of commercialization activities required to bring Mount Sinais inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, while also negotiating agreements for sponsored research, material transfer, and confidentiality.
Early Stage VC - LP Investor via LSFO
2024
Critical Venture Partners is an inception stage venture capital firm that partners with exceptional students tackling major crises.
Show all 13 entries ↓
Investment activity
2020–2024 · 5 investments
2020120244
Recent (last 2 years)Earlier